InspireMD, Inc. NSPR
0.76 USD -0.04 (-4.92%)
Nov 12, 2026, 2:39 PM EST
0.66 Day range 0.80
0.43 52-week range 2.22
- YTD
- -57.27%
- 1 year
- -57.51%
Benzinga news
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares increased by 27.9% to $2.79 during Friday's pre-market session. The company's market cap stands at $5.2 million. Picard Medical (AMEX:PMI) stock…
- benzinga.com Full Transcript: InspireMD Q2 2026 Earnings Call InspireMD (NASDAQ:NSPR) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday's pre-market session. The company's market cap stands at $7.0 million. Aligos Therapeutics (NASDAQ:ALGS)…
benzinga.com Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket Dell Technologies (DELL) stock jumps in pre-market trading after reporting better-than-expected Q2 results and raising FY27 guidance. Other gainers include UPC, GTLB, VIVK, UFG, MLEC, FFAI, GPUS,…
benzinga.com InspireMD Q2 EPS $(0.17) Beats $(0.19) Estimate, Sales $1.771M Miss $2.133M Estimate InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 34.62 percent increase over losses of $(0.26)…
benzinga.com InspireMD Announces 30-Day Outcomes From CGUARDIANS II Clinical Trial Of CGuard Prime 80cm Implant For Use In Transcarotid Artery Revascularization Procedures InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced 30-day outcomes from the CGUARDIANS II…- benzinga.com InspireMD Announces First Patient Enrolled In CGUARDIANS III Pivotal Study Of SwitchGuard Neuro Protection System, For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the first patient has been…
benzinga.com Piper Sandler Reiterates Overweight on InspireMD, Lowers Price Target to $3 Piper Sandler analyst Adam Maeder reiterates InspireMD (NASDAQ:NSPR) with a Overweight and lowers the price target from $4 to $3.- benzinga.com Transcript: InspireMD Q1 2026 Earnings Conference Call
benzinga.com InspireMD Q1 EPS $(0.16) Beats $(0.19) Estimate, Sales $3.398M Beat $2.698M Estimate InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 27.27 percent increase over losses of $(0.22)…
benzinga.com Earnings Scheduled For May 4, 2026 
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com InspireMD Withdraws Prior Full Year 2026 Revenue Guidance; Says Given The Impact Of The Temporary Discontinuation Of Commercial Activity In The U.S. Pending The Anticipated FDA Approval Of Its Original CGuard Stent Delivery System In Q3 2026 2026 Financial GuidanceConcurrent with today's announcement, the Company is withdrawing its prior full year 2026 revenue guidance. Management believes this is the most prudent step given the impact…
- benzinga.com InspireMD Initiates Voluntary U.S. Recall Of CGuard Prime 135cm Carotid Stent Delivery System; Recall Follows Technical Performance Of CGuard Prime 135cm Not Meeting Expectations; Recall Does Not Include CGuard Stent Implant; FDA Approval Of CGuard Prime 80cm For TCAR Anticipated In 2H 2026; FDA Approval, U.S. Availability Of Original CGuard Delivery System Anticipated In Q3 2026; Implementing Design Improvements To CGuard Prime Stent Delivery System - Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% - - FDA approval anticipated with U.S. market…
- benzinga.com InspireMD Initiates Voluntary Recall For Its CGuard Prime 135 Cm Carotid Stent Delivery System InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD," or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that, in consultation with the U.S.…
- benzinga.com InspireMD Says FDA Approves IDE Application To Initiate CGUARDIANS III Pivotal Study Of SwitchGuard NPS, Including Next Gen Enhancements From Prior IDE Approval For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the U.S. Food and Drug…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - benzinga.com Earnings Scheduled For March 18, 2026
- benzinga.com InspireMD Q4 EPS $(0.14) Beats $(0.19) Estimate, Sales $3.149M Beat $2.626M Estimate InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 27.46 percent. This is a 26.32 percent increase over losses of $(0.19)…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com InspireMD Publishes Data From Its C-GUARDIANS Pivotal Study Journal Of The American College of Cardiology InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that results from the Company's…
benzinga.com InspireMD CREST-2 Data Demonstrates Addition Of Stenting Improves Outcomes In Trial For Participants With Asymptomatic Carotid Stenosis InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, welcomes the recent presentation and publication of…
benzinga.com Earnings Scheduled For November 4, 2025 
benzinga.com Earnings Scheduled For August 5, 2025 - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Earnings Scheduled For May 9, 2025
- benzinga.com Earnings Scheduled For March 12, 2025
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com Earnings Scheduled For March 6, 2024 Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
- benzinga.com Earnings Scheduled For November 6, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
- benzinga.com Earnings Scheduled For August 8, 2023 Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 - benzinga.com Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
benzinga.com Earnings Scheduled For May 15, 2023 Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.
benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.- benzinga.com Earnings Scheduled For March 30, 2023 Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 236 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 53 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 101 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 142 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 456 stocks hit new 52-week lows.